STAT
SEPTEMBER 6, 2023
BRISTOL, Va. — When Wes Adams’ youngest son was little, he’d sometimes toddle over to the TV, pop in a cassette, and watch himself being born. It was a home video, filmed by his older brother. There was his mother, her belly anesthetized but her head very much awake, asking the doctors to keep the incision small, please. There was his dad’s medical partner, making the cut for the C-section.
Pharmacy Times
SEPTEMBER 6, 2023
The fixed-dose abacavir/dolutegravir/lamivudine combination is indicated for the once-daily treatment of children weighing at least 6 kg to <25 kg with HIV-1 infection.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 6, 2023
South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the government to pay more than the European Union but offered little protection against delivery failures, according to an advocacy group. For instance, Johnson & Johnson charged South Africa $10 a dose, 15% more than the company charged the European Union, while the government was required to pay a non-refundable down payment of $27.5 million.
Drug Topics
SEPTEMBER 6, 2023
The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 6, 2023
More older adults have been hospitalized for Covid-19 over the past several weeks, according to internal data reviewed by health insurance giant Humana. Humana, which mostly provides health insurance to those 65 and older and who are therefore more vulnerable to the worst effects of Covid, expected more Covid cases and hospitalizations this year. But it didn’t expect the uptick to come during the waning summer months.
Fierce Healthcare
SEPTEMBER 6, 2023
Chronic kidney disease (CKD) is a major blind spot for many Americans, a new survey suggests. | Though many respondents used the internet for medical information and had a regular doctor and blood work done once or twice a year, 58% of respondents were unfamiliar with the illness.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
SEPTEMBER 6, 2023
YouTube announced two programs Thursday that the Google-owned video platform said will give healthcare content creators new opportunities to educate diverse audiences. | The two new initiatives leverage cultural representation and targeted messaging to reach audiences impacted by health inequity, Google's Garth Graham, M.D., said.
Pharmacy Times
SEPTEMBER 6, 2023
In addition to overall survival, main efficacy outcomes, such as progression-free survival, objective response rate, and time to response, were compared to chemotherapy alone.
STAT
SEPTEMBER 6, 2023
“Lots of scrambling on the ground.” That’s how Consuelo Wilkins, the senior associate dean for health equity and inclusive excellence at Vanderbilt University Medical Center, describes medical schools’ current efforts to maintain diversity in the wake of the U.S. Supreme Court’s decision to strike down affirmative action based on race.
Pharmacy Times
SEPTEMBER 6, 2023
Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 6, 2023
Looking at the dizzying progress in cancer medicine over the last couple of decades, it’s easy to imagine that advances in synthetic biology or immunology will soon help cure or prevent more cancers. But without a strategy to connect “these miracles” to all communities, only some will benefit and others will be left behind, said Robert Winn, the director of the Massey Cancer Center at Virginia Commonwealth University.
Pharmacy Times
SEPTEMBER 6, 2023
Norgestrel (Opill) for pregnancy prevention will be accessible at various retail locations, including drug stores, convenience stores, grocery stores, and online platforms.
STAT
SEPTEMBER 6, 2023
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare pricing power over therapies that both cost Medicare lots of money and have by 2026 enjoyed market exclusivity for a certain number of years — nine for small-molecule drugs and 13 for biologics.
Fierce Healthcare
SEPTEMBER 6, 2023
Unite Us, tech company focused on social determinants of health, lays off employees amid profitability struggles agliadkovskaya Wed, 09/06/2023 - 14:25
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
SEPTEMBER 6, 2023
IBM disclosed "unauthorized access" to J&J’s Janssen CarePath patient assistance program, which helped over 1 million U.S. patients last year.
STAT
SEPTEMBER 6, 2023
If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday. Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides.
Fierce Healthcare
SEPTEMBER 6, 2023
The American Hospital Association (AHA) is among those pushing back against the Federal Trade Commission’s (FTC's) plans to update pre-merger notification requirements, calling the proposal “a subs | "There is no need to subject hospitals to burdensome rules aimed at other sectors of the economy,” the AHA wrote of amendments to the Hart-Scott-Rodino Form proposed in June.
Pharmacy Times
SEPTEMBER 6, 2023
Cases of certain HPV-related high-grade disease were not found in the 10-year follow up for girls and boys who received 3 doses of the Gardasil 9 injection.
Fierce Pharma
SEPTEMBER 6, 2023
Expecting to be subject to Medicare pricing negotiations, Astellas in July challenged the legality of the Inflation Reduction Act (IRA). | Expecting to be subject to Medicare pricing negotiations, Astellas in July challenged the legality of the Inflation Reduction Act. But now that the Centers for Medicare & Medicaid Services has released the first 10 drugs set for governmental bargaining, the company is ready to abandon its litigation.
Pharmacy Times
SEPTEMBER 6, 2023
An upcoming large-scale clinical trial of the Glucose Everyday Matters program will evaluate its safety and efficacy in managing type 2 diabetes.
Fierce Pharma
SEPTEMBER 6, 2023
Johnson & Johnson’s Rybrevant is currently approved for a tiny non-small cell lung cancer (NSCLC) niche. | Johnson & Johnson’s Rybrevant is currently approved for a tiny non-small cell lung cancer niche. A late-stage study could move the drug to a larger disease area where AstraZeneca’s blockbuster Tagrisso plays, but the most important readout still lies ahead.
Fierce Healthcare
SEPTEMBER 6, 2023
Research shows that Medicare spending has leveled off for the past decade, morphing from something that experts worried might break the federal budget to an unexpected bright spot. | Medicare had once been seen as something that would one day break the budget. However, Medicare spending in the last decade slowed greatly. But why?
Fierce Pharma
SEPTEMBER 6, 2023
AstraZeneca’s Ultomiris expansion plan has hit a snag in the U.S. | The FDA handed the company a complete response letter for its Ultomiris application in neuromyelitis optica spectrum disorder, a rare autoimmune disease affecting the central nervous system.
Drug Topics
SEPTEMBER 6, 2023
Many women seek out abortion medications, but this process has seen increased barriers as options become restricted by federal and state regulations.
Fierce Pharma
SEPTEMBER 6, 2023
Royalty Pharma, a company known for ponying up chunks of cash in exchange for long-term drug royalties, has hopped on board with Ascendis Pharma's long-acting growth hormone Skytrofa. | Ascendis hopes to bring its second TransCon product to the market and overcome manufacturing issues. Meanwhile, the company's Skytrofa is going up against a new competitor in Pfizer and OPKO Health's Ngenla.
Fierce Healthcare
SEPTEMBER 6, 2023
When the Affordable Care Act (ACA) was passed in 2010, the legislation set forth requirements for insurers to cover lactation services for mothers, a stark contrast from expecting families to pay o | The Affordable Care Act says insurance companies must front the cost for lactation care. Many are still not doing so, forcing other providers to step up.
Fierce Pharma
SEPTEMBER 6, 2023
Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.
Fierce Healthcare
SEPTEMBER 6, 2023
Former UnitedHealthcare executive Roger Rodriguez said that during his tenure with the insurance giant, he endeavored to view payer issues through a provider lens. | Former UnitedHealthcare executive Roger Rodriguez said that during his tenure with the insurance giant, he endeavored to view payer issues through a provider lens.
Drug Topics
SEPTEMBER 6, 2023
Previous clinical data has shown that the vaccine also generates a strong response to the EG.5 and FL.1.5.1 variants.
Drug Store News
SEPTEMBER 6, 2023
C&S could announce the deal to acquire most or all of the stores that Albertsons and Kroger are divesting for antitrust reasons as soon as this week, per a Bloomberg report.
STAT
SEPTEMBER 6, 2023
Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot campus than from our ritual cup of stimulation (which happens to be coconut rum today). But this is to be expected at this time of year, yes? In any event, there is work to be done, so as always, we have assembled a few items of interest for you.
The Checkup by Singlecare
SEPTEMBER 6, 2023
A runny nose isn’t usually serious, but that doesn’t mean it isn’t bothersome or uncomfortable. A runny nose can cause congestion , make breathing more difficult, interrupt sleep, and may be accompanied by other annoying symptoms like coughing and sneezing. If you’re dealing with these issues, you probably want some relief. Many simple remedies for runny noses include at-home treatments like hot compresses, steam treatments, and over-the-counter medications like antihistamines and decongestant
Drug Store News
SEPTEMBER 6, 2023
The limited-edition Sally Hansen Insta-Dri x Trolls collection features eight new pearl and creme finish shades that reflect the energy of the Trolls universe, the company said.
Fierce Healthcare
SEPTEMBER 6, 2023
If there’s one thing we know about rare diseases, it’s that their prevalence is not so rare. | The rare disease journey can be long and difficult. rWGS could offer newborns a greater chance of successful diagnosis and intervention at birth.
Expert insights. Personalized for you.
145 
Let's personalize your content